WLPWM
NVAX icon

Walled Lake Planning & Wealth Management’s Novavax NVAX Stock Holding History

Walled Lake Planning & Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 352
2019
Q4 		$0 Buy
+100
New +$434 ﹤0.01% 274

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walled Lake Planning & Wealth Management's NVAX Position: Q1 2020 in Review

Walled Lake Planning & Wealth Management sold out of Novavax (NVAX) in Q1 2020, closing a stake of 100 shares.

Walled Lake Planning & Wealth Management first reported a position in NVAX in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 117 funds tracked by Wall St. Rank hold NVAX as of Q1 2020.

  • Walled Lake Planning & Wealth Management reported no remaining Novavax position as of Q1 2020 after selling out during the quarter.
  • Walled Lake Planning & Wealth Management sold 100 Novavax shares in Q1 2020.
  • Walled Lake Planning & Wealth Management first reported a position in Novavax in Q4 2019 and held it in 1 quarter.
  • Walled Lake Planning & Wealth Management's Novavax position peaked at $0 in Q4 2019.
  • 117 funds tracked by Wall St. Rank held Novavax as of Q1 2020.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q1 2020, filed 15 May 2020.